<html>
<head>PUBMED IDs for HOXA-AS2</head>
<body bgcolor='#C5F0F2'><h1>HOXA-AS2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/23649634/'>HOX antisense lincRNA HOXA-AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cells.</a> March 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26384350/'>Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression.</a> September 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27855366/'>HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.</a> November 18  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28112720/'>Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer.</a> January 24  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28545023/'>Long non-coding RNA HOXA-AS2 promotes proliferation and invasion of breast cancer by acting as a miR-520c-3p sponge.</a> May 26  2017<br></body></html>
